Detention of HPV L1 Capsid Protein and hTERC Gene in Screening of Cervical Cancer

Objective(s): To investigate the expression of human papilloma virus (HPV) L1 capsid protein, and human telomerase RNA component (hTERC) in cervical cancer and the role of detection of both genes in screening of cervical cancer. Materials and Methods: A total of 309 patients were recruited and cervical exfoliated cells were collected. Immunocytochemistry was employed to detect HPV L1 capsid protein, and fluorescent in situ hybridization (FISH) was performed to detect the hTERC. Results: The expression of HPV L1 capsid protein reduced with the increase of the histological grade of cervical cells and was negatively related to the grade of cervical lesions. However, the expression of hTERC increased with the increase of the histological grade and positively associated with the grade of cervical lesions. The proportion of patients with L1(-)/hTERC(+) was higher in patients with histological grade of CIN2 or higher than that in those with histological grade of CIN1. The L1(+)/hTERC(-) and L1(-)/hTERC(-) were negatively related to the grade of cervical lesions. L1(-)/hTERC(+) was positively associated with the grade of cervical lesions. The L1/hTERC ratio increased. The negative predictive value of both HPV L1 and hTERC was higher than that of HPV L1 or hTERC, but there was no marked difference in the screening efficacy of cervical cancer among HPV L1, hTERC and HPV L1+hTERC. Conclusion: HPV L1 capsid protein and hTERC gene may serve as markers for the early diagnosis and prediction of cervical lesions. The increase in L1/hTERC ratio reflects the progression of cervical lesions to a certain extent.

[1]  K. Nayereh,et al.  Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers , 2012, Iranian journal of basic medical sciences.

[2]  I. Takač,et al.  Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions. , 2009, Cancer genetics and cytogenetics.

[3]  S. Serrano,et al.  3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases. , 2009, Human pathology.

[4]  Yong Dai,et al.  Gain of the Human Telomerase RNA Gene TERC at 3q26 is Strongly Associated With Cervical Intraepithelial Neoplasia and Carcinoma , 2009, International Journal of Gynecologic Cancer.

[5]  W. Huh.  Human Papillomavirus Infection: A Concise Review of Natural History , 2009, Obstetrics and gynecology.

[6]  C. Jung,et al.  Expression of HPV L1 capsid protein in cervical specimens with HPV infection , 2008, Diagnostic cytopathology.

[7]  Wessel N van Wieringen,et al.  Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer , 2008, Genes, chromosomes & cancer.

[8]  P. Delvenne,et al.  Detection of HPV-induced Cervical (Pre) Neoplastic Lesions: A Tissue Microarray (TMA) Study , 2008, Applied immunohistochemistry & molecular morphology : AIMM.

[9]  M. Beckmann,et al.  Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[10]  M. Guo,et al.  Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. , 2008, Gynecologic oncology.

[11]  R. Reddel,et al.  Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells , 2008, Cancer science.

[12]  T. Nakajima,et al.  Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid‐based cytology samples from uterine cervical lesions , 2008, Cancer.

[13]  J. Hariri,et al.  Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker. , 2008, Analytical and quantitative cytology and histology.

[14]  M. Guo,et al.  Gain of the 3 q 26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma , 2008 .

[15]  K. Shroyer,et al.  Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma , 2007, Cancer.

[16]  F. Smedts,et al.  Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer , 2006, The Journal of pathology.

[17]  R. Roden,et al.  How will HPV vaccines affect cervical cancer? , 2006, Nature Reviews Cancer.

[18]  M. Beckmann,et al.  Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions , 2006 .

[19]  K. Lewandowski,et al.  Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. , 2006, Oncology reports.

[20]  A. Klingelhutz,et al.  Human Papillomavirus Type 16 E6 Activates NF-κB, Induces cIAP-2 Expression, and Protects against Apoptosis in a PDZ Binding Motif-Dependent Manner , 2006, Journal of Virology.

[21]  M. Grace,et al.  Mechanisms of Human Papillomavirus-Induced Oncogenesis , 2004, Journal of Virology.

[22]  P. Rao,et al.  Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma , 2004, BMC Cancer.

[23]  M. Sherman,et al.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. , 2003, The American journal of pathology.

[24]  B. McMahon,et al.  Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers , 2003, Oncogene.

[25]  E. Franco,et al.  Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.

[26]  Chi-Hung Lin,et al.  Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. , 2001, Cancer genetics and cytogenetics.

[27]  T. Westbrook,et al.  Biology of human papillomaviruses , 2001, International journal of experimental pathology.

[28]  S. Garland,et al.  Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer , 2000, British Journal of Cancer.

[29]  N. Kiviat,et al.  Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. , 2000, The Journal of infectious diseases.

[30]  N. Tanaka,et al.  Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. , 2000, Cancer genetics and cytogenetics.

[31]  C. Wheeler,et al.  Risk factors for rapid-onset cervical cancer. , 1999, American journal of obstetrics and gynecology.

[32]  Y. Yaginuma,et al.  Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears. , 1998, European journal of cancer.

[33]  Lydia P. Howell,et al.  NATURAL HISTORY OF CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[34]  J. McDougall,et al.  Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. , 1998, The American journal of pathology.

[35]  Genes, chromosomes & cancer , 1995 .